CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure — Stella

Home/Graft Failure/

View on ClinicalTrials.gov

Recruiting

Back to Graft Failure trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

NYU Langone Health, New York, New York

Key details

Sponsor

NYU Langone Health

Enrollment target

~21 participants

Started

October 2024

Primary completion

August 2034

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.